Literature DB >> 26189599

Influence of thyroid dysfunction on serum levels of angiopoietin-like protein 6.

Jung Ah Lim1, Hyo Jeong Kim2, Hwa Young Ahn3, Kyoung Un Park4, Ka Hee Yi5, Do Joon Park5, Hak Chul Jang5, Young Joo Park6.   

Abstract

Angiopoietin-like protein 6 (ANGPTL6) is a novel metabolic regulator that modulates energy expenditure as well as glucose and lipid metabolism. Thyroid hormone can induce metabolic changes that are similar to those induced by ANGPTL6. Herein, we investigated whether circulating ANGPTL6 levels change according to thyroid hormone status in humans. We measured the serum levels of ANGPTL6 and metabolic parameters in 150 drug-naïve subjects with overt hyperthyroid, subclinical hyperthyroid, euthyroid, subclinical hypothyroid, or overt hypothyroid status (n=30 in each group). Serum ANGPTL6 levels were significantly higher in patients with overt hypothyroidism than in the other subjects. Women had significantly higher serum levels of ANGPTL6 than men. ANGPTL6 levels correlated positively with thyroid stimulating hormone (TSH), total cholesterol, aspartate aminotransferase, and alanine aminotransferase (ALT) and negatively with serum free thyroxine (T4) level. Multiple stepwise linear regression analysis revealed that sex, TSH, free T4, and ALT were independent predictors of serum ANGPTL6 levels. In summary, serum ANGPTL6 levels increased in patients with a hypothyroid status, and both TSH and free T4 levels are associated with ANGPLT6 levels, suggesting a possible association between thyroid function and ANGPTL6 levels. Whether the upregulated ANGPTL6 level in the hypothyroid status is primarily owing to a direct association or a compensatory mechanism remains to be determined.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adipokines; Angiopoietin-like 6 protein; Human; Thyroid

Mesh:

Substances:

Year:  2015        PMID: 26189599     DOI: 10.1016/j.metabol.2015.06.015

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  4 in total

Review 1.  Relationship between the development of hyperlipidemia in hypothyroidism patients.

Authors:  Xin Su; Xiang Chen; Bin Wang
Journal:  Mol Biol Rep       Date:  2022-09-12       Impact factor: 2.742

2.  Association between serum TSH levels and metabolic components in euthyroid subjects: a nationwide population-based study.

Authors:  Rui Ren; Yu Ma; Fang Deng; Tao Li; Hongyan Wang; Jing Wei; Xiaoyan Jiang; Min He; Mingyuan Tian; Dongfang Liu; Bing Chen; Wuquan Deng
Journal:  Diabetes Metab Syndr Obes       Date:  2019-08-22       Impact factor: 3.168

Review 3.  Update on dyslipidemia in hypothyroidism: the mechanism of dyslipidemia in hypothyroidism.

Authors:  Huixing Liu; Daoquan Peng
Journal:  Endocr Connect       Date:  2022-02-07       Impact factor: 3.335

Review 4.  Novel insights into the pathological development of dyslipidemia in patients with hypothyroidism.

Authors:  Xin Su; Xiang Chen; Hua Peng; Jingjin Song; Bin Wang; Xijie Wu
Journal:  Bosn J Basic Med Sci       Date:  2022-06-01       Impact factor: 3.759

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.